NCT03543241 is a clinical trial of MyoStrain in Coronary Artery Disease, sponsored by Myocardial Solutions.

Who is sponsoring NCT03543241?

NCT03543241 is sponsored by Myocardial Solutions.

What drugs are being tested in NCT03543241?

Interventions in NCT03543241: MyoStrain.

What condition does NCT03543241 study?

NCT03543241 studies Coronary Artery Disease, Myocardial Ischemia, Myocardial Dysfunction.

Is NCT03543241 still recruiting?

NCT03543241 is currently completed. Last updated 19 December 2018.

Last reviewed 2018-12-19 · How we verify

NCT03543241

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MyoStrain CMR Testing of Ischemia With Low Levels of Stress

Completed Last updated 19 December 2018

What this trial tests

trial testing MyoStrain in Coronary Artery Disease in 13 participants. Completed in 18 October 2018.

Timeline

8 November 2017

Primary endpoint
12 September 2018

18 October 2018

Quick facts

Lead sponsor	Myocardial Solutions
Status	Completed
Study type	OBSERVATIONAL
Enrollment	13
Start date	8 November 2017
Primary completion	12 September 2018
Estimated completion	18 October 2018
Sites	1 location across United States

Drugs / interventions tested

MyoStrain

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →
Myocardial Ischemia — all drugs for Myocardial Ischemia →
Myocardial Dysfunction — all drugs for Myocardial Dysfunction →

Sponsor

Myocardial Solutions

Who can join

Adults 18 to 80, any sex, with Coronary Artery Disease or Myocardial Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, observational study evaluates the accuracy of stress testing with the MyoStrain SENC CMR Imaging System to detect myocardial ischemia and viability in patients with suspected coronary artery disease using low levels of stress.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of MyoStrain

Trials testing the same drug.

NCT03543228 — MyoStrain CMR for the Detection of Cardiotoxicity · completed

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03543241 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Myocardial Solutions
Last refreshed: 19 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03543241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing